TREATMENT OF MALIGNANT GLIOMAS WITH MITOXANTRONE‐LOADED POLY (LACTIDE‐CO‐GLYCOLIDE) MICROSPHERES

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neurosurgery

• Publication date

  2006-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1227/01.NEU.0000245607.99946.8FPMID 17277693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surgifoam and Mitoxantrone in the Glioblastoma Multiforme Postresection Cavity: The First Step of Locoregional Chemotherapy through an Ad Hoc-placed Catheter: Technical Note

  2006cited by this paper
• Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial

  2006cited by this paper
• Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma

  2005cited by this paper
• Novel Advances in Drug Delivery to Brain Cancer

  2005cited by this paper
• Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.

  2005cited by this paper
• Formulation and in vitro bioactivity of mitoxantrone-loaded biodegradable microspheres on rat glioma (RG2) cells

  2005cited by this paper
• Pharmacology of mitoxantrone: mode of action and pharmacokinetics

  2004cited by this paper
• In vitro cytotoxicity of mitoxantrone-incorporated albumin microspheres on acute promyelocytic leukaemia cells

  2004cited by this paper
• Development of novel 5-FU-loaded poly(methylidene malonate 2.1.2)-based microspheres for the treatment of brain cancers.

  2004cited by this paper
• Intralesional Mitoxantrone Biopolymer-Mediated Chemotherapy Prolongs Survival in Rats with Experimental Brain Tumors

  2004cited by this paper
• A model for intratumoural chemotherapy in the rat brain

  2004cited by this paper
• Quantification of in vivo doxorubicin transport from PLGA millirods in thermoablated rat livers.

  2003cited by this paper
• A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

  2003cited by this paper
• Preparation of poly(DL-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid.

  2003cited by this paper
• Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats.

  2002cited by this paper
• Preparation, characterization and in vivo evaluation of 120-day poly(D,L-lactide) leuprolide microspheres.

  2001cited by this paper
• Preparation and characterization of gelatin surface modified PLGA microspheres

  2001cited by this paper
• Injectable Chemotherapeutic Microspheres and Glioma I: Enhanced Survival Following Implantation into the Cavity Wall of Debulked Tumors

  2000cited by this paper
• Development of microspheres for neurological disorders: from basics to clinical applications.

  2000cited by this paper
• Injectable Chemotherapeutic Microspheres and Glioma II: Enhanced Survival Following Implantation into Deep Inoperable Tumors

  2000cited by this paper
• Chemosensitivity of glioma cells in vitro: a meta analysis

  1999cited by this paper
• Evaluation of mitoxantrone-loaded albumin microspheres following intraperitoneal administration to rats.

  1999cited by this paper
• Preparation and Characterization of Poly (D,L-Lactide-Co-Glycolide) Microspheres for Controlled Release of Poly(L-Lysine) Complexed Plasmid DNA

  1999cited by this paper
• The delivery of BCNU to brain tumors.

  1999cited by this paper
• Local and sustained delivery of 5‐fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma

  1999cited by this paper
• Mitoxantrone-DHAP with GM-CSF: an active but myelosuppressive salvage therapy for relapsed/refractory aggressive non-Hodgkin's lymphoma.

  1999cited by this paper
• Implantable Slow-Release Chemotherapeutic Polymers for the Treatment of Malignant Brain Tumors.

  1998cited by this paper
• Drug delivery into the brain using implantable polymeric systems

  1997cited by this paper
• Mitoxantrone-induced DNA strand breaks in cell-cultures of malignant human astrocytoma and glioblastoma tumors

  1997cited by this paper
• Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study.

  1997cited by this paper
• Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.

  1997cited by this paper
• Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.

  1996cited by this paper
• Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.

  1996cited by this paper
• Intratumoral chemotherapy.

  1995cited by this paper
• Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas

  1995cited by this paper
• Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.

  1995cited by this paper
• A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model.

  1995cited by this paper
• Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.

  1995cited by this paper
• Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remission

  1994cited by this paper
• Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.

  1994cited by this paper
• Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.

  1993cited by this paper
• Controlled cisplatin delivery system using poly(D,L-lactic acid).

  1992cited by this paper
• Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.

  1991cited by this paper
• Chemical induction of brain tumors in rats by nitrosoureas: molecular biology and neuropathology.

  1989cited by this paper
• Human autopsy tissue concentrations of mitoxantrone.

  1986cited by this paper
• Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells.

  1981cited by this paper
• Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells.

  1980cited by this paper
• Effects of 9,10-anthracenedione, 1,4-bis[(2-[(2-hydroxyethyl)amino]-ethyl)amino]-diacetate on cell survival and cell cycle progression in cultured mammalian cells.

  1979cited by this paper

• Encapsulation-based enhancements in modern drug delivery systems.

  2025cites this paper
• A dataset on formulation parameters and characteristics of drug-loaded PLGA microparticles

  2025cites this paper
• Polymer nanocarriers for targeted local delivery of agents in treating brain tumors

  2022cites this paper
• Biomaterials: Emerging systems for study and treatment of glioblastoma

  2022cites this paper
• A Comprehensive Review on Nanomedicine: Promising approach for treatment of brain tumor through intranasal administration.

  2022cites this paper
• The biomedical significance of multifunctional nanobiomaterials: The key components for site-specific delivery of therapeutics.

  2021cites this paper
• Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration.

  2020cites this paper
• Novel therapeutics for brain tumors: current practice and future prospects

  2020cites this paper
• Drug and disease signature integration identifies synergistic combinations in glioblastoma

  2018cites this paper
• Intratumoral temozolomide in spontaneous canine gliomas: feasibility of a novel therapy using implanted microcylinders

  2018cites this paper
• Nanoparticles reshape the biomedical industry

  2018cites this paper
• Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model.

  2017cites this paper
• Farnesylthiosalicylic acid‐loaded lipid–polyethylene glycol–polymer hybrid nanoparticles for treatment of glioblastoma

  2017cites this paper
• ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia

  2017cites this paper
• Designing of Natural Anticancerous Drugs and Their Delivery System

  2017cites this paper
• A potential non‐invasive glioblastoma treatment: Nose‐to‐brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles

  2017cites this paper
• Anticancer Plants: Clinical Trials and Nanotechnology

  2017cites this paper
• Safety, feasibility, and optimization of intra-arterial mitoxantrone delivery to gliomas

  2016cites this paper
• Drug encapsulated aerosolized microspheres as a biodegradable, intelligent glioma therapy.

  2016cites this paper
• Study of the interactions of surface-modified particles with membrane model systems

  2016cites this paper
• Polymer Particulates in Drug Delivery.

  2016cites this paper
• Drug encapsulated polymeric microspheres for intracranial tumor therapy: A review of the literature.

  2015cites this paper
• Nanocarrier-based therapies for CNS tumors.

  2014cites this paper
• Biomaterial strategies to modulate cancer

  2013cites this paper
• Therapeutics, imaging and toxicity of nanomaterials in the central nervous system.

  2012cites this paper
• Chemotherapy for brain tumors with polymer drug delivery.

  2012cites this paper
• Treatment of Experimental Brain Metastasis with MTO-Liposomes: Impact of Fluidity and LRP-Targeting on the Therapeutic Result

  2012cites this paper
• Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis

  2012cites this paper
• Polymeric nanoparticles for drug delivery to the central nervous system.

  2012cites this paper
• Intra-arterial Mitoxantrone Delivery in Rabbits: An Optical Pharmacokinetic Study

  2011cites this paper
• Nano to micro delivery systems: targeting angiogenesis in brain tumors

  2010cites this paper
• The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles.

  2010cites this paper
• Current advances in research and clinical applications of PLGA-based nanotechnology

  2009cites this paper
• Conventional and gene therapy strategies for the treatment of brain tumors.

  2008cites this paper
• Modulating liposomal stealth properties to evade RES and target tumors.

  2008cites this paper
• Polymeric nanoparticles for cancer therapy

  2008cites this paper
• Biomaterials for the central nervous system

  2008cites this paper
• Literature alerts

  2007cites this paper
• Biodegradable intraprostatic doxorubicin implants

  2007cites this paper